Portage Biotech Inc. (PRTG) Dividend History

Portage Biotech Inc. is a biotechnology company focused on developing innovative therapies in immuno-oncology, infectious diseases, and other areas. The company emphasizes the advancement of novel drug candidates through clinical development and strategic collaborations to address unmet medical needs in various disease areas.

Dividend History

Portage Biotech Inc. currently does not pay dividends

Company News

  • Portage Biotech reports positive preclinical data for its selective adenosine A2B receptor inhibitor PORT-7 in a murine mesothelioma model, demonstrating superior single-agent activity compared to anti-PD1 antibody and further improvement in combination. The company plans to commence a first-in-human clinical trial with PORT-7.

    GlobeNewswire Inc.
  • Portage Biotech announced the resumption of patient enrollment in the final cohort of the dose escalation stage for its selective A2A antagonist, PORT-6, within its ADPORT-601 Phase 1b clinical trial. The company is also preparing to evaluate the continuation of the study into its potent and selective A2B antagonist, PORT-7, and combination arms.

    GlobeNewswire Inc.
  • Portage Biotech is re-launching its wholly-owned adenosine receptor antagonist subsidiary as an independently managed company, Cyncado Therapeutics, with Peter Molloy as the new CEO. The company aims to advance the clinical development of its portfolio of A2a and A2b receptor antagonists, which have the potential to enhance the immune system's ability to fight cancer.

    GlobeNewswire Inc.
  • Tellurian Inc. shares rose sharply after Woodside Energy announced plans to acquire the company for $900 million. Several other stocks also saw significant pre-market movement, both positive and negative.

    Benzinga
    Featured Companies: CISO NCPL OFG ONCO RR SERV SGD SLRX VEEE
  • Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier. Travelers shares dipped 8.1% to $205.03 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024. Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results. Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350. VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday. AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70. The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider. EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market. CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461. WiSA Technologies, Inc. (NASDAQ:

    Benzinga
Dividend data last updated 06/07/2025 15:31:01 UTC